Catalyst Wire Dossier Catalyst Wire Dossier

Ledipasvir and Sofosbuvir

Ledipasvir and Sofosbuvir · Asegua Therapeutics LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Ledipasvir and Sofosbuvir, covering 2016-02-12 to 2024-12-19. Get the full timeline:

Most recent: FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)

See pricing